du Bois R M
Royal Brompton National Heart and Lung Hospital, London, United Kingdom.
Annu Rev Med. 1993;44:441-50. doi: 10.1146/annurev.me.44.020193.002301.
Idiopathic pulmonary fibrosis kills half of its victims within five years of diagnosis. Currently available treatment regimens are disappointing, and the incidence of the disease appears to be increasing. Newer techniques of imaging coupled with laboratory advances in molecular and cellular biology may produce new strategies for modulating the disease process. This article explores new approaches to the diagnosis and management of idiopathic pulmonary fibrosis.
特发性肺纤维化患者在确诊后五年内，半数会死亡。目前可用的治疗方案效果不佳，且该病的发病率似乎正在上升。更新的成像技术与分子和细胞生物学领域的实验室进展相结合，可能会产生调控疾病进程的新策略。本文探讨了特发性肺纤维化诊断和管理的新方法。
